DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.70, $0.09 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.29 billion.

GUIDANCE:

DexCom sees FY2026 revenue of $5.18-5.25 billion, versus the consensus of $5.22 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.